Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKSE: 1276) is trading at HK$45.18, about ₹553 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 0.75% today. Indian residents can buy Jiangsu Hengrui Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$44.32
Today's high
HK$45.64
52 week low
HK$43.02
52 week high
HK$95.20
1276 opened at HK$45.52, closed previously at HK$45.52, and has traded between HK$43.02 and HK$95.20 over the past 52 weeks.
About
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Key statistics
Avg. volume
4.68M
Market cap
HK$299.87B
P/E Ratio
38.02
Price-to-sales ratio
9.14
Enterprise value
HK$248.15B
Free cash flow yield
1.99%
Debt-to-equity ratio
0.01
Return on equity
12.42%
ROIC
10.01%
Beta
0.12
Dividend yield
0.45%
Last dividend
HK$0.23
Financial overview
Revenue
HK$35.19B
Earnings per share
HK$1.32
Free cash flow
HK$9.20B
Net profit margin
24.67%
Gross margin
85.34%
EBITDA
HK$10.64B
Revenue growth
18.20%
How to buy Jiangsu Hengrui Pharmaceuticals from India
Indian residents can buy Jiangsu Hengrui Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Jiangsu Hengrui Pharmaceuticals and place an order
Find Jiangsu Hengrui Pharmaceuticals by name or by its ticker, 1276, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Jiangsu Hengrui Pharmaceuticals trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Jiangsu Hengrui Pharmaceuticals position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Jiangsu Hengrui Pharmaceuticals from India
Trading and taxes when buying Jiangsu Hengrui Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Jiangsu Hengrui Pharmaceuticals’ current yield is 0.45%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Jiangsu Hengrui Pharmaceuticals stock?
Yes. Jiangsu Hengrui Pharmaceuticals (1276) has been listed on the Hong Kong Stock Exchange since 2025, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Jiangsu Hengrui Pharmaceuticals share cost in rupees?
One Jiangsu Hengrui Pharmaceuticals share is HK$45.18 — about ₹553 at an HKD/INR rate of 12.25 on 24 Sep 2026. Both the Jiangsu Hengrui Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Jiangsu Hengrui Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Jiangsu Hengrui Pharmaceuticals?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Jiangsu Hengrui Pharmaceuticals shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Jiangsu Hengrui Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Jiangsu Hengrui Pharmaceuticals pay a dividend, and how is it taxed in India?
Yes. Jiangsu Hengrui Pharmaceuticals pays a dividend and the current yield is 0.45%; the last declared dividend was HK$0.23 per share, about ₹2.80. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Jiangsu Hengrui Pharmaceuticals from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Jiangsu Hengrui Pharmaceuticals a Hong Kong SAR China company, and does that change how it is taxed?
Jiangsu Hengrui Pharmaceuticals trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Jiangsu Hengrui Pharmaceuticals trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Jiangsu Hengrui Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Jiangsu Hengrui Pharmaceuticals holding, its cost and its closing value.
How do I sell Jiangsu Hengrui Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.